FDA Inspection 1106423 — Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
The FDA completed an inspection of Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. on September 10, 2019 in Tokushima. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 10, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tokushima (Japan)